Endoscopic evaluation and factors affecting the endoscopic efficacy during granulomonocytapheresis in moderately-to-severely active ulcerative colitis: a multi-centre retrospective study

被引：0
|
作者：
Yamamoto, T. [1 ]
Iida, T. [2 ]
Ikeya, K. [2 ]
Kato, M. [2 ]
Matsuura, A. [2 ]
Tamura, S. [3 ]
Takano, R. [3 ]
Tani, S. [4 ]
Osawa, S. [4 ]
Sugimoto, K. [3 ]
Shimoyama, T. [1 ]
Hanai, H. [2 ]
机构：
[1] Yokkaichi Hazu Med Ctr, IBD Ctr, Yokaichi, Japan
[2] Hamamatsu South Hosp, Ctr Gastroenterol & Inflammatory Bowel Dis Res, Hamamastu, Japan
[3] Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka, Japan
[4] Hamamatsu Univ Sch Med, Dept Endoscop & Photodynam Med, Hamamatsu, Shizuoka, Japan
来源：
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词：
D O I：
10.1093/ecco-jcc/jjy222.644
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P520
引用
下载
收藏
页码：S372 / S373
页数：2
相关论文
共 50 条
  • [1] Factors affecting the efficacy of granulomonocytapheresis in moderately-to-severely active ulcerative colitis: A multi-centre retrospective study
    Yamamoto, T.
    Iida, T.
    Ikeya, K.
    Kato, M.
    Matsuura, A.
    Tamura, S.
    Takano, R.
    Tani, S.
    Osawa, S.
    Sugimoto, K.
    Shimoyama, T.
    Hanai, H.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S354 - S354
  • [2] Endoscopic and Histologic Remission After 2 Years Treatment With Mirikizumab in Patients With Moderately-to-Severely Active Ulcerative Colitis
    Margo, Fernando
    Peyrin-Biroulet, Laurent
    Kobayashi, Taku
    Jairath, Vipul
    Walsh, Alissa
    Christensen, Britt
    Wu, Jianmin
    Park, Gina
    Redondo, Isabel
    Sands, Bruce E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S812 - S812
  • [3] IMPROVED ENDOSCOPIC OUTCOMES AND MUCOSAL HEALING OF UPADACITINIB AS AN INDUCTION THERAPY IN ADULTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS: DATA FROM THE U-ACHIEVE STUDY
    Sandborn, William J.
    Schreiber, Stefan
    Lee, Scott D.
    Lindsay, James O.
    Hebuterne, Xavier
    Zhou, Wen
    Cataldi, Fabio
    Lacerda, Ana P.
    Huang, Bidan
    Xie, Wangang
    Loftus, Edward V.
    GASTROENTEROLOGY, 2019, 156 (06) : S170 - S171
  • [4] COST PER RESPONSE, REMISSION AND ENDOSCOPIC IMPROVEMENT OF ADVANCED THERAPIES OF BIO-EXPOSED PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS (UC) IN FRANCE
    Wang, S. T.
    Sanchez, Y.
    Villemant-Robin, S.
    VALUE IN HEALTH, 2022, 25 (12) : S160 - S160
  • [5] Efficacy and Safety of Advanced Therapies in Moderately-to-Severely Active Ulcerative Colitis: a Systematic Review and Network Meta-analysis
    Axel Dignass
    Claire Ainsworth
    Susanne Hartz
    Niels Dunnewind
    Isabel Redondo
    Christophe Sapin
    Sonja Kroep
    Nicholas Halfpenny
    Emanuele Arcà
    Sami Hoque
    Advances in Therapy, 2024, 41 (12) : 4446 - 4462
  • [6] REDUCTION IN INFLAMMATORY BIOMARKERS IN A PHASE 2 STUDY OF MIRIKIZUMAB IN THE TREATMENT OF PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS
    Sandborn, William J.
    Sands, Bruce E.
    Kobayashi, Taku
    Tuttle, Jay
    Schmitz, Jochen
    Durante, Michael
    Higgs, Richard E.
    Canavan, James
    Siegel, Robert
    Ferrante, Marc
    GASTROENTEROLOGY, 2019, 156 (06) : S1094 - S1095
  • [7] An economic evaluation of tofacitinib for the treatment of moderately-to-severely active ulcerative colitis: modeling the cost of treatment strategies in the United States
    Milev, Sandra
    DiBonaventura, Marco DaCosta
    Quon, Peter
    Goh, Jo Wern
    Bourret, Jeffrey
    Peeples-Lamirande, Kathleen
    Soonasra, Arif
    Cappelleri, Joseph C.
    Quirk, Daniel
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (09) : 859 - 868
  • [8] A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis (vol 9, 170, 2018)
    Yamamoto, Takayuki
    Iida, Takayuki
    Ikeya, Kentaro
    Kato, Masaichi
    Matsuura, Ai
    Tamura, Satoshi
    Takano, Ryosuke
    Tani, Shinya
    Osawa, Satoshi
    Sugimoto, Ken
    Shimoyama, Takahiro
    Hanai, Hiroyuki
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2018, 9
  • [9] EFFECT OF PHARMACOKINETICS AND IMMUNOGENICITY ON CLINICAL AND ENDOSCOPIC EFFICACY IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM THE SEAVUE STUDY
    Panaccione, Remo
    Sands, Bruce E.
    Danese, Silvio
    Irving, Peter M.
    Hoops, Timothy
    Izanec, James L.
    Ma, Tony
    Adedokun, Omoniyi J.
    Gasink, Christopher
    Kuehbacher, Tanja
    Patel, Kamal V.
    Filip, Rafal
    Allez, Matthieu
    Scherl, Ellen J.
    Sandborn, William J.
    GASTROENTEROLOGY, 2022, 162 (07) : S963 - S963
  • [10] A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis (vol 9, 170, 2018)
    Yamamoto, Takayuki
    Iida, Takayuki
    Ikeya, Kentaro
    Kato, Masaichi
    Matsuura, Ai
    Tamura, Satoshi
    Takano, Ryosuke
    Tani, Shinya
    Osawa, Satoshi
    Sugimoto, Ken
    Shimoyama, Takahiro
    Hanai, Hiroyuki
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2018, 9
12345